IDEC-Y2B8 at Medical Drugs Glossary

What is IDEC-Y2B8? An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called yttrium Y90 ibritumomab tiuxetan.

Medical Term & Definition Added By: Madison

Send To Friends!

If you'd like to send the IDEC-Y2B8 definition to yourself or to your friends/colleagues, just enter the e-mail addresses in the boxes below -

We hope you now understand the meaning of IDEC-Y2B8. If you need any more information on this term, please don't hesitate to contact us.

Other Similar Drugs Terms:

Prescription Drugs Term Fingerprint is Any technique that enables the identification of substances by the comparison of patterns. Examples include DNA, protein, peptide, and chemical fingerprinting.

Prescription Drugs Term palpation is Examination by pressing on the surface of the body to feel the organs or tissues underneath.

Prescription Drugs Term CC-8490 is A substance that is being studied in the treatment of brain cancer. It belongs to the family of drugs called benzopyrans.

Prescription Drugs Term Transition state is The initial state of a substrate molecule bound to the active site of an enzyme. The transition state is followed by the formation of more stable intermediates prior to product formation.

Prescription Drugs Term neuroma (noo-RO-ma) is A tumor that arises in nerve cells.